Tag: Parliamentary Question

  • Andrew Rosindell – 2016 Parliamentary Question to the Home Office

    Andrew Rosindell – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Andrew Rosindell on 2016-01-06.

    To ask the Secretary of State for the Home Department, how many refugees who have been admitted to the UK since 2010 (a) have since returned to their country of origin and (b) her Department is in regular contact with.

    James Brokenshire

    If the Home Office grants refugee status to an applicant, we would not seek to remove them from the UK as a ‘failed asylum seeker’. It has been assumed the question is about how many refugees who have settled in the UK, have since returned to their country of origin.

    The Home Office does not hold information on the number of people who have settled and been granted refugee status in the UK, who have since returned to their country of origin. If refugees return to their country of origin the Home Office does not keep in regular contact.

  • Lord Fearn – 2015 Parliamentary Question to the Department for Energy and Climate Change

    Lord Fearn – 2015 Parliamentary Question to the Department for Energy and Climate Change

    The below Parliamentary question was asked by Lord Fearn on 2015-11-03.

    To ask Her Majesty’s Government how many wind farms there are in United Kingdom waters off the coast of England, and where they are situated.

    Lord Bourne of Aberystwyth

    There are a total of 23 offshore wind farms off the coast of England with a combined installed capacity of 4181MW. These wind farms are located:-

    Offshore Wind Farm

    MW Capacity

    Region

    Inner Dowsing

    108.0

    East Midlands

    Lincs

    270.0

    East Midlands

    Lynn

    86.4

    East Midlands

    Gunfleet Sands Demo

    12.0

    East of England

    Gunfleet Sands II

    64.8

    East of England

    Gunfleet Sands Offshore Wind Scheme

    108.0

    East of England

    Scroby Sands

    60.0

    East of England

    Greater Gabbard Wind Farm

    504.0

    East of England

    Sheringham Shoal

    317.0

    East of England

    Teeside Offshore Wind Farm

    62.1

    North East

    Blyth Offshore

    4.0

    North East

    Burbo Bank

    90.0

    North West

    Walney 1

    183.6

    North West

    Walney 2

    183.6

    North West

    Barrow

    90.0

    North West

    West of Duddon Sands

    389.0

    North West

    Ormonde Offshore

    150.0

    North West

    Kentish Flats

    90.0

    South East

    Thanet

    300.0

    South East

    Kentish Flats Extension

    49.5

    South East

    London Array

    630.0

    South East

    Humber Gateway

    219.0

    Yorkshire and Humber

    Westermost Rough

    210.0

    Yorkshire and Humber

  • Lord Patten – 2015 Parliamentary Question to the Department for Transport

    Lord Patten – 2015 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Lord Patten on 2015-11-30.

    To ask Her Majesty’s Government whether they intend to announce plans before 2020 to replace the single track railway lines between Salisbury and Exeter with double track railway lines in order to further promote economic growth in that region.

    Lord Ahmad of Wimbledon

    In August 2015 Network Rail published the outcome of the Wessex and Western Route Studies undertaken by the rail industry. This includes a review of the future demand on the line between London, Salisbury and Exeter.

    The Government expects to set out in July 2017 its investment plan for the railways during 2019 to 2024 and will take account of the industry proposals in developing this plan.

  • Lord Laird – 2016 Parliamentary Question to the Northern Ireland Office

    Lord Laird – 2016 Parliamentary Question to the Northern Ireland Office

    The below Parliamentary question was asked by Lord Laird on 2016-01-12.

    To ask Her Majesty’s Government how they define parity of esteem as set out in the Belfast Agreement 1998.

    Lord Dunlop

    As I have made clear in previous answers on this subject the UK Government is committed to affording due respect and parity of esteem to all the people in Northern Ireland as underpinned by the 1998 Belfast Agreement, and in accordance with the obligations on the Government to promote equality and prevent discrimination across the United Kingdom.

  • Sadiq Khan – 2016 Parliamentary Question to the Department of Health

    Sadiq Khan – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Sadiq Khan on 2016-02-03.

    To ask the Secretary of State for Health, how many referrals there were to Child and Mental Health services in (a) England, (b) each London borough and (c) each health trust in London in each year since 2010.

    Alistair Burt

    This information is not held centrally.

  • Lord Clement-Jones – 2016 Parliamentary Question to the Department of Health

    Lord Clement-Jones – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Clement-Jones on 2016-02-24.

    To ask Her Majesty’s Government when they expect a reimbursement decision on each of the drugs launched since June 2015 that were affected by the pause in listing new drugs on the Cancer Drugs Fund list.

    Lord Prior of Brampton

    Since June 2015, the National Institute for Health and Care Excellence (NICE) has published final technology appraisal guidance on the cancer drugs/indications listed in the following table.

    Topic title

    Final guidance publication

    Melanoma (unresectable, metastatic) – pembrolizumab (after ipilimumab) [TA357]

    October 2015

    Melanoma (unresectable, metastatic, ipilimumab naive) – pembrolizumab [TA366]

    November 2015

    Multiple myeloma – panobinostat (post 1 prior therapy) [TA380]

    January 2016

    Melanoma (advanced, unresectable, metastatic) – nivolumab [TA384]

    February 2016

    NHS England has advised that it envisages, under the new arrangements for the Cancer Drugs Fund (CDF), that a greater number of cancer drugs will be funded from baseline commissioning. Under the new process, any drugs that receive either a draft recommendation for routine commissioning or, where uncertainty exists, a recommendation for use within the CDF, will receive interim funding from the CDF from the point of marketing authorisation.

    NICE has advised that it is unable to provide a forecast as to when this will occur for technology appraisals published during the first year of the new CDF as this will depend on a number of factors including the value proposition put forward by manufacturers.

  • Owen Smith – 2016 Parliamentary Question to the Department for Work and Pensions

    Owen Smith – 2016 Parliamentary Question to the Department for Work and Pensions

    The below Parliamentary question was asked by Owen Smith on 2016-04-25.

    To ask the Secretary of State for Work and Pensions, pursuant to the Answer of 18 April 2016 to Question 33700, what steps his Department is taking to monitor levels of funeral poverty.

    Justin Tomlinson

    The Government recognises that some families on low incomes can struggle to meet the costs of a funeral, this is why the Social Fund Funeral Expenses Payments covers specified necessary costs and provides a significant contribution of up to £700 towards the fee levied by funeral directors for all other funeral expenses.

    My Department continues to look at the effectiveness of the scheme so that it provides effective support and will keep on monitoring its effectiveness and liaising with stakeholders and interested groups so that it maintains its aim of providing a contribution towards the cost of a funeral.

  • The Countess of Mar – 2016 Parliamentary Question to the Department for Work and Pensions

    The Countess of Mar – 2016 Parliamentary Question to the Department for Work and Pensions

    The below Parliamentary question was asked by The Countess of Mar on 2016-06-07.

    To ask Her Majesty’s Government what form of evidence of incapacity is acceptable for Personal Independence Payments claims when a person suffering from severe myalgic encephalomyelitis or chronic fatigue syndrome, for which there is currently no treatment, has had no contact with any medical professionals or auxiliary practitioners for a considerable length of time.

    Baroness Altmann

    The Department encourages claimants to provide as much relevant evidence as necessary to support their claim. The “How your disability affects you” form and accompanying guidance sets out the range of information that can help the Department reach a decision. The guidance for Health Professionals also sets out sources of further evidence which could help inform their advice to the Department, this includes family members, carers or anyone else who supports them.

    Before claimants are invited for a face-to-face consultation, all of the evidence held is reviewed and if, at that stage, a decision can be made on the paper evidence alone, then claimants will not be required to attend a face-to-face consultation. Alternatively, further evidence that might help inform the Department’s decision on the claim can be requested by the Health Professional.

    If the Health Professional cannot provide advice to the Department at this stage, or where there is insufficient or no other suitable sources of evidence on which to make an assessment, claimants will be invited to attend a face-to-face consultation. This gives claimants the opportunity to put across their own views of the impact of their health condition on their everyday lives, ensuring that decisions reflect the best evidence. In some cases we carry out consultations in the claimant’s home.

  • Stephen Doughty – 2016 Parliamentary Question to the Department for International Development

    Stephen Doughty – 2016 Parliamentary Question to the Department for International Development

    The below Parliamentary question was asked by Stephen Doughty on 2016-07-20.

    To ask the Secretary of State for International Development, whether she plans to delay or revisit the (a) bilateral aid review and (b) multilateral aid reviews in response to the EU referendum result.

    Rory Stewart

    The Secretary of State is currently considering the outcomes of the Department for International Development’s Multilateral and Bilateral Aid Reviews, ahead of their publication.

  • Norman Lamb – 2016 Parliamentary Question to the Department of Health

    Norman Lamb – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Norman Lamb on 2016-10-11.

    To ask the Secretary of State for Health, what assessment he has made of the potential effect of proposed changes in the level of community pharmacy funding on 100 hour pharmacies.

    David Mowat

    The Government’s proposals for community pharmacy in 2016/17 and beyond, on which we have consulted, are being considered against the public sector equality duty, the family test and the relevant duties of my Rt. hon. Friend, the Secretary of State for Health under the National Health Service Act 2006. Our assessment considers a range of potential impacts in respect to the adequate provision of NHS pharmaceutical services and access to NHS pharmaceutical services, including supplementary hours and 100 hours per week pharmacies. An impact assessment will be completed to inform final decisions and published in due course.

    Our aim is to ensure that those community pharmacies upon which people depend continue to thrive. We are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared with others, considering factors such as location and the health needs of the local population.

    An impact assessment will be completed to inform final decisions and published in due course.

    Our aim is to ensure that those community pharmacies upon which people depend continue to thrive. We are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared with others, considering factors such as location and the health needs of the local population.